Non-Coding RNA is a prestigious open-access journal published by MDPI, based in Switzerland, dedicated to the significant and rapidly evolving field of non-coding RNA research. Established in 2015, this journal has quickly become an essential resource for researchers and professionals, showcasing innovative studies and breakthroughs related to the functions and mechanisms of non-coding RNAs in various biological processes. With an impressive Q1 ranking in Biochemistry and strong rankings in Genetics and Molecular Biology, Non-Coding RNA consistently reflects the highest standards of academic publishing. The journal provides comprehensive access options, granting researchers worldwide the ability to disseminate and access high-quality research without subscription barriers. As the landscape of genomics and molecular discoveries continues to expand, the journal aims to foster interdisciplinary exchanges and collaborations, making it a vital platform for advancing knowledge and innovation in this critical area of biological science.

Nucleus is a distinguished academic journal published by Taylor & Francis Inc, dedicated to advancing the fields of Cell Biology and Medicine. Since its inception, the journal has gained significant recognition, achieving a Q1 ranking in both Cell Biology and Medicine (miscellaneous) categories in 2023. With a focus on innovative research that intersects molecular biology and genetics, Nucleus serves as a vital platform for researchers and professionals aiming to disseminate findings that contribute to our understanding of cellular mechanisms and their implications in health and disease. The journal's commitment to Open Access since 2018 ensures that cutting-edge research is readily available to the global community, fostering collaboration and engagement across disciplines. Located in Philadelphia, PA, Nucleus not only aims to publish high-quality articles but also aspires to influence future research directions in the biological sciences, making it an essential resource for anyone involved in the life sciences.

Israel Journal of Chemistry is a leading international journal published by Wiley-VCH Verlag GmbH, dedicated to advancing the field of chemistry through high-quality research publications. With an impressive Q1 ranking in the Chemistry (Miscellaneous) category of the 2023 Scopus rankings and a solid percentile standing of 73rd, this journal plays a vital role in disseminating significant findings to a global audience. Established in 1963, it has maintained a legacy of excellence in chemistry until 2024, covering a wide range of topics including organic, inorganic, physical, and analytical chemistry. While not offering open access, the journal remains a crucial resource for researchers, professionals, and students seeking to enhance their knowledge and contribute to the field. With its rigorous peer-review process and commitment to scientific integrity, the Israel Journal of Chemistry continues to be a beacon of innovation and scholarship in the ever-evolving landscape of chemical research.

DNA RESEARCH is a pioneering open-access journal published by Oxford University Press, dedicated to advancing the field of genetics and molecular biology. Since its inception in 1994, the journal has been at the forefront of scientific innovation, providing a global platform for researchers to publish high-quality findings that drive the understanding of DNA and its implications in medicine. With an impactful presence characterized by a Q2 ranking in Genetics, a Q1 ranking in Medicine (miscellaneous), and a Q2 ranking in Molecular Biology as per the latest 2023 assessments, DNA RESEARCH stands as a vital resource for both established scholars and emerging scientists. The journal's diverse range of articles caters to a wide audience, fostering collaboration and the sharing of knowledge. Researchers, professionals, and students alike will find an abundance of cutting-edge research and insights that can inform their work and further their understanding of this critical scientific domain. For more information and to access articles, visit the journal's website at Oxford University Press.

CHROMOSOMA is a prestigious journal dedicated to advancing the field of genetics, published by Springer in Germany. With an ISSN of 0009-5915 and an E-ISSN of 1432-0886, this journal has been a cornerstone in the publishing landscape since its inception in 1939, serving as a critical resource for researchers and professionals interested in the intricacies of chromosomal biology. Although it operates on a subscription basis, the journal's rigorous peer-review process ensures the dissemination of high-quality research findings. With a commendable Q2 ranking in both genetic and clinical genetics categories as of 2023, CHROMOSOMA aims to bridge theoretical concepts with practical applications in medicine and biology. Researchers will appreciate its relevance, as indicated by its Scopus ranks and integration of diverse topics ranging from molecular genetics to clinical implications. By fostering collaboration and knowledge-sharing among scholars, CHROMOSOMA continues to shape the future of genetic research.

Epigenetics, published by Taylor & Francis Inc, is a leading journal in the fields of Cancer Research, Medicine (miscellaneous), and Molecular Biology. With an ISSN of 1559-2294 and an E-ISSN of 1559-2308, this journal has been paving the way for groundbreaking research since its inception in 2006, and it continues to play a crucial role in advancing our understanding of epigenetic mechanisms and their implications in health and disease. The journal is highly regarded, ranking in the Q1 category for Medicine and Q2 for both Cancer Research and Molecular Biology according to the 2023 category quartiles. Researchers and professionals in the field will find invaluable insights and innovative studies within its pages, making it an essential resource for those engaged in cutting-edge research. Although the journal is not open access, it encourages a comprehensive understanding through high-quality peer-reviewed content. With its creative exploration of the epigenetic landscape, Epigenetics serves as a vital platform for the sharing of knowledge that could lead to breakthroughs in treatments and therapies.

Molecular Therapy Nucleic Acids is a premier open-access journal published by CELL PRESS, dedicated to advancing the field of molecular medicine through the innovative application of nucleic acid-based therapies. Since its inception in 2012, this journal has become an essential resource for researchers and professionals in drug discovery and molecular medicine, reflected in its status as a Q1 journal in both categories for 2023. With a notable impact factor and high rankings in Scopus, including #8 out of 157 in Drug Discovery and #16 out of 178 in Molecular Medicine, it serves to disseminate groundbreaking research and foster collaborations among scientists worldwide. The journal's comprehensive scope encompasses a wide variety of topics, including gene therapy, RNA interference, and CRISPR technology, ensuring that it remains at the forefront of scientific excellence. With open access availability, Molecular Therapy Nucleic Acids actively promotes the widespread dissemination of knowledge, making its crucial insights accessible to students, researchers, and industry professionals alike.

RNA Biology is a premier journal published by Taylor & Francis Inc, focusing on the intricate and evolving field of RNA research. With an ISSN of 1547-6286 and E-ISSN of 1555-8584, this journal has established itself as an essential resource for professionals, researchers, and students engaged in both molecular and cell biology. Recognized in the 2023 quartile rankings, RNA Biology holds a distinguished Q1 category in Molecular Biology and a Q2 category in Cell Biology, indicative of its significant impact and reputation within the scientific community. The journal emphasizes the importance of RNA in various biological processes, highlighting both fundamental and applied aspects, which is crucial for advancing our understanding of gene expression and regulation. With a strong Scopus ranking, including Rank #105/410 in Molecular Biology and Rank #83/285 in Cell Biology, RNA Biology is not just a publication but a vital platform for sharing groundbreaking findings and insights into RNA research. With a convergence that spans from 2004 to 2024, the journal promises to continue its legacy of excellence in disseminating important discoveries in RNA science, contributing richly to ongoing scientific dialogue and innovation.

Non-coding RNA Research, published by KEAI PUBLISHING LTD, is a leading open-access journal dedicated to advancing the field of non-coding RNA, a critical component in the landscape of molecular biology and genetics. Established in 2016, this journal aims to provide a platform for the dissemination of high-quality research focusing on the roles, mechanisms, and therapeutic potentials of non-coding RNAs in various biological processes and diseases. With impressive Scopus rankings placing it in the top quartile for both Biochemistry and Medical Biochemistry, as well as notable standings in Genetics and Molecular Biology, Non-coding RNA Research continues to attract contributions from globally recognized experts. The journal's commitment to open access ensures broad visibility and engagement with cutting-edge discoveries, thereby fostering an inclusive scientific dialogue that enhances understanding and innovation in this rapidly evolving field. For researchers and scholars, the opportunity to publish in a Q1 ranked journal not only validates their work but also enhances its impact, making Non-coding RNA Research an indispensable resource for anyone interested in the intricate workings of non-coding RNA.

MOLECULAR BIOLOGY OF THE CELL is a prestigious journal published by the American Society for Cell Biology, focusing on the latest advancements in cell biology and molecular biology. Established in 1990, this journal serves as a vital forum for disseminating innovative research, methodologies, and insights that drive the understanding of cellular processes and their implications in health and disease. With a noteworthy impact factor and recognition within the top quartiles for both Cell Biology and Molecular Biology, it ranks prominently among its peers, with Scopus rankings reflecting its significance in the scientific community. Although the journal does not follow an open access model, it provides essential access options for both institutional and personal subscriptions. Researchers, professionals, and students seeking to expand their knowledge and collaborate on groundbreaking findings will find MOLECULAR BIOLOGY OF THE CELL an invaluable resource in the field.